Phase I–IV clinical research with comprehensive therapeutic coverage
Our multisite structure allows for conducting clinical trials with safety, precision, and predictability. We operate with international quality standards, ensuring consistent deliveries for the global pharmaceutical industry.
research participants
20,000 m² of complete infrastructure, ready for clinical studies
Sites in Campinas and São Paulo, Brazil
Phase I and First-in-Human (FIH) studies
Our inpatient units were designed to conduct studies with safety, rigorous clinical oversight, and immediate response capability.
Integrated and multidisciplinary coordination
The support areas of Synvia work in coordination with the clinical teams, ensuring that each study is conducted with technical precision, regulatory compliance, and operational efficiency.
Excellence in quality, safety, and regulatory-scientific compliance
Global Regulatory Compliance
Full compliance with Good Clinical Practices (ICH E6 R2), ANVISA, and international standards, ensuring auditable and traceable studies.
Essential documentation for audits and submissions:
Synvia TrialCore, the digital core of clinical research
An integrated ecosystem of software solutions that organizes, connects, and scales clinical operations, from study planning to completion.
Extensive experience in multiple therapeutic areas
Our studies cover various medical specialties and specialized technical teams.
Pharma Solutions
Integrated solutions for the pharmaceutical industry
From clinical research to laboratory analyses and regulatory studies, our Pharma solutions connect all the necessary steps for the development, validation, and registration of medications.
For doctors
Join the Medical Referring Program
For patients
Join a clinical study
Synvia conducts studies that evaluate new treatment possibilities for various health conditions, with safety and ethical rigor.